New catheter valve offers hope for High-Risk heart patients
NCT ID NCT03339115
Summary
This study is testing the safety and performance of a new artificial heart valve, called the Cardiovalve, for people with a severely leaking mitral valve. The valve is designed to be delivered through a catheter in the leg vein, avoiding open-heart surgery. It is being tested in 30 patients who are at high risk for traditional surgery, with doctors tracking their health and valve function for two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O.U. Pisana
Pisa, 56126, Italy
-
Fondazione Toscana G. Monasterio-Ospedale del Cuore
Massa, 54100, Italy
-
Herzzentrum der Uniklinik Köln
Cologne, Germany
-
Hygea
Athens, Greece
-
Klinikum der Universität München LMU
München, Germany
-
Maria Cecilia Hospital
Cotignola, Italy
-
Policlinico San Donato
Milan, Italy
-
San Raffaele Hospital
Milan, 20129, Italy
-
Studienzentrale der Medizinische Klinik II Universitäres Herzzentrum Lübeck
Lübeck, Germany
-
Universitaet_Mainz
Mainz, Germany
-
Universitätsklinikum Bonn
Bonn, North Rhine-Westphalia, 53127, Germany
Conditions
Explore the condition pages connected to this study.